QualityStocksNewsBreaks – CytoDyn Inc. (CYDY) Advances Development of HIV Single Agent Therapy
Biotechnology company CytoDyn (OTCQB: CYDY) recently reported significant developmental progress during phase 3 trials for its PRO 140 monotherapy for…
Blog
Pressure BioSciences Inc. (PBIO) Reports Significant Financial and Operational Achievements during Highly Successful Q2
Pressure BioSciences Inc. announced strong financial results for the second quarter of 2018, demonstrating the company’s growth and stability Products…
Independent Researchers at SeeThruEquity Take Note of Advances at Payment Solutions Company Net Element, Inc. (NASDAQ: NETE)
Rise in transaction volume, product enhancements and asset acquisition show Net Element’s ongoing growth strategy SeeThruEquity labels Net Element an…
QualityStocksNewsBreaks – Zenergy Brands, Inc. (ZNGY) Reports Q2 Financial Results
Next-generation energy and technology company Zenergy Brands (OTC: ZNGY) this morning announced that it has filed its Form 10-Q with…
QualityStocksNewsBreaks – FANDOM SPORTS Media Corp. (CSE: FDM) (OTC: FDMSF) (FRA: TQ42) Unveils New FANbassador Program
Fan-focused entertainment company FANDOM SPORTS Media Corp. (CSE: FDM) (OTC: FDMSF) (FRANKFURT: TQ42) this morning unveiled its new FANbassador…
QualityStocksNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Technology Continues to Demonstrate Versatility
Lexaria Bioscience (CSE: LXX) (OTCQB: LXRP) is the developer of a disruptive drug delivery platform, DehydraTECH™, that the company out-licenses…
QualityStocksNewsBreaks –The Flowr Corp. Secures Sales License from Health Canada
The Flowr Corp., a cultivator of premium cannabis in Canada, recently announced that it has received its sales license from…
CytoDyn Inc. (CYDY) Sees Promising HIV Treatment Trial Results, Gets Go-Ahead to Raise Dosage
Response rate to PRO 140 rose from 40 percent at 350mg dose to 70 percent at 525mg Institutional Review Board…
MIDS Cardiac by Zenosense, Inc. (ZENO): A Heart Attack Diagnostic Revolution?
The handheld testing device technology under development by Zenosense aims to deliver rapid results and state-of-the-art, laboratory-accurate results for the…
QualityStocksNewsBreaks – Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) and WeedMD Inc. (TSX-V: WMD) (OTC: WDDMF) (FSE: 4WE) Ink Definitive JV Agreement to Develop Cannabis Beverages Inc.
Phivida Holdings (CSE: VIDA) (OTCQX: PHVAF), together with WeedMD (TSX-V: WMD) (OTC: WDDMF) (FSE: 4WE), this morning announced that the…